Metrics Inc., one of the nation’s fastest growing contract pharmaceutical development laboratories, has expanded its presence on the West Coast through the addition of business development services.
The company has appointed Jeff Boris to serve as its business development specialist, helping clients on the West Coast with new projects and contracts.
“Expanding Metrics’ services to the West Coast was a logical next step in our plans to continue growth within the contract pharmaceutical development industry,” said Phil Hodges, president. “We are excited to have Jeff join the Metrics team and help us to deliver our services to our West Coast clients.”
Jeff brings more than 20 years of sales experience in the pharmaceutical industry to the Metrics team. He has worked with formulation and analytical development, preclinical services and clinical studies of new pharmaceutical products for pharmaceutical and biotech companies. Jeff earned his bachelor’s of science degree from Purdue University.
During the past year, Metrics has doubled its facility size to more than 90,000 square feet of pharmaceutical development and manufacturing space. The company now has the ability to provide one-stop development from initial formulation through Phase I, II and III clinical materials and final commercial production. Metrics also added a dedicated potent and cytotoxic drug development facility that can accommodate Phase I through III projects.
About Metrics, Inc.
Metrics (metricsinc.com), headquartered in Greenville, N.C., is one of the fastest-growing contract pharmaceutical development laboratories in the United States. Metrics provides quality pharmaceutical formulation, clinical trial material (Phase I, II and III) and commercial manufacturing, and analytical development/validation services to the pharmaceutical industry.